Dr. Florence Cabot, MD

Dr. Cabot practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Cabot's NPI, 1477805273, was assigned on October 4, 2012. Dr. Cabot graduated from Paul Sabatier Univ in 2006. Dr. Cabot holds Florida license MFC1796.

Dr. Cabot's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Cabot's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Cabot to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cabot practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Cabot's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Cabot is licensed in Florida.

Dmand AI lists cataract, cataract surgery with lens implant, dry eye, hereditary corneal conditions, secondary membranaous cataract surgery and vision problems among the conditions Dr. Cabot treats.

CMS data shows 528 Medicare services from Dr. Cabot across 8 procedure codes in 2024, for 310 Medicare patients. Medicare paid $96,432 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 310 Medicare patients who saw Dr. Cabot in 2024. The largest group is 65 to 74, with 121 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cabot's median patient age at 73, with 61% women.

In 2024, Dr. Cabot wrote 1,392 Medicare Part D claims for 402 patients. 49% of them were for generic drugs. CMS names the drug for 1,330 of them, across 10 drugs with 11 or more claims each, at $68,214 in total drug cost. In 2023, CMS named 1,689 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Cabot for performance year 2024, reported as part of a group. Dr. Cabot accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 210 procedures of cataract surgery by Dr. Cabot, more than 84% of the clinicians it reports for that procedure.

Dmand AI links 36 papers to Dr. Cabot, published from 2013 to 2022. 2014 was the busiest year, with 4. The most frequent topics are Cataract Extraction, Visual Acuity and Lenses, Intraocular. Dr. Cabot has published most often in J Refract Surg. Dr. Cabot's most frequent co-authors are Sonia H. Yoo, MD, Priyanka Chhadva, MD and Vasilios Frank Diakonis, MD.

CMS Open Payments shows 162 general payments to Dr. Cabot from 22 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 59% of the total. Alcon Laboratories Inc paid the most, $8,412.

Dr. Cabot graduated from Paul Sabatier Univ in 2006.

Dr. Cabot is in network with 11 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.